<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209713</url>
  </required_header>
  <id_info>
    <org_study_id>17-336</org_study_id>
    <nct_id>NCT03209713</nct_id>
  </id_info>
  <brief_title>Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination</brief_title>
  <acronym>Edtech-HPV</acronym>
  <official_title>Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a two-arm randomized controlled trial, implemented to assess the effectiveness
      of a community-based educational program with and without a text messaging reminder system,
      in increasing the rate of HPV vaccination completion among children of Mexican Americans.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaccination completion assessment rate</measure>
    <time_frame>2 years</time_frame>
    <description>Comparison rates of vaccination completion will be assessed by Fisher's exact test.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Parents</condition>
  <arm_group>
    <arm_group_label>Parental Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive parental education on HPV vaccine and the vaccine's benefits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parental Education + Text Messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HPV Vaccine Education</intervention_name>
    <description>A one on one twenty-minute parental educational program providing facts about HPV, HPV-related cancers, and the HPV vaccine.</description>
    <arm_group_label>Parental Education</arm_group_label>
    <arm_group_label>Parental Education + Text Messaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text Messaging Reminder</intervention_name>
    <description>Participants will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after participating in the education session. These reminders will occur until uptake of the first dose of the vaccine is reported or for up to 12 weeks.</description>
    <arm_group_label>Parental Education + Text Messaging</arm_group_label>
    <other_name>EdTech-HPV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Born in Mexico or born in U.S. but self-describes as Mexican-American

          -  Spanish is his or her primary language

          -  Has a minimum of one child between the ages of 11 and 17 who has not received the HPV
             vaccine

          -  Self-identifies as the child's main caregiver

          -  Currently owns a cell phone and uses text messaging services and is willing to accept
             text messages for this study

          -  21 to 84 years old

        Exclusion Criteria:

          -  Presence of a serious psychiatric or cognitive impairment likely to preclude
             meaningful informed consent and adherence to the protocol per the consenting
             professional's judgment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abraham Aragones, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abraham Aragones, MD, MS</last_name>
    <phone>646-888-8058</phone>
    <email>aragonea@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francesca Gany, MD, MS</last_name>
    <phone>646-888-8054</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alivio Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ester Corpuz</last_name>
      <phone>773-254-1400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Research, Education and Access to Community Health (REACH)</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebeca Aceves Zaragoza</last_name>
      <phone>702-477-2755</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abraham Aragones, MD, MS</last_name>
      <phone>646-888-8058</phone>
    </contact>
    <contact_backup>
      <last_name>Francesca Gany, MD, MS</last_name>
      <phone>646-888-8054</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The University of Texas at El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79968</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Moya, PhD</last_name>
      <phone>915-747-8493</phone>
    </contact>
    <investigator>
      <last_name>Eva Moya, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://mskcc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mexican</keyword>
  <keyword>Mexican-American</keyword>
  <keyword>17-336</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

